Toplumda Yaşayan Yaşlılarda Mini-Cog Testinin Demans Taramasındaki Etkinliğinin Mmse, Q-Mcı ve Moca Testleriyle Kıyası: Bir Saha Çalışması
Göster/ Aç
Tarih
2019-01Yazar
Özdemir , Setenay Dilara
Ambargo Süresi
Acik erisimÜst veri
Tüm öğe kaydını gösterÖzet
It is important to screen the common dementia along with aging
population with an effective and easy test. In this field study, it is aimed to
compare the success of Mini-Cog in diagnosis with the common cognitive
function screening tests and to be used it in primary care if it is found
effective. In this study, a total of 4 family health centers with different sociocultural levels were identified, 115 patients, 65 years and older, who had
dysmnesia were screened and the study was completed with 51 patients who
met the criteria. After detailed medical history, Mini-Cog test was applied to
all patients and the patients who couldn’t have the full score were performed
routine blood tests and other cognitive screen tests called MMSE, Qmci-TR,
MoCA and their cognitive and extensive geriatric evaluation were done in
Hacettepe University, Department of Internal Medicine, Geriatri Polyclinic. As
a result of the evaluation, 42 of 51 patients were accepted as mild cognitive
disorder and 9 patients were diagnosed with dementia according to DSM-V
criteria. According to the results, the difference of total score between
dementia patients and normal patients was not statistically significant (MiniCog (p = 0.131), MoCA (p = 0.539) and MMSE (p = 0.097)), while the
difference of Qmci-TR total score was statistically significant (p = 0.027).
While dementia was detected in only 6 (%22,2) of 27 patients with
decompensated Mini-Cog test, dementia was detected in 3 (%12,5) of 24
patients with a normal Mini-Cog score. There was no statistically significant
correlation between Mini-Cog test defect and dementia diagnosis (p = 0.363).
Mini-Cog word repetition was significantly different between dementia and
normal group (p = 0.010). As a result, Mini-Cog test could not be shown to be
effective in dementia screening. Larger scale studies are needed to support
and improve the results.